Author(s)

Smadar Valérie Tourjman^1*, Miriam H. Beauchamp², Akram Djouini¹, Mathilde Neugot-Cerioli², Charlotte Gagner², Philippe Baruch³, Serge Beaulieu⁴, Florence Chanut⁵, Andrée Daigneault⁴, Robert-Paul Juster¹, Sonia Montmayeur⁶, Stéphane Potvin¹, Scot Purdon⁷, Suzanne Renaud⁵, Evens Villenneuve³

¹Institut Universitaire en Santé Mentale de Montréal, Montreal, Canada.
²Centre de Recherche de l’H?pital Ste-Justine, Montreal, Canada.
³Institut Universitaire en Santé Mentale de Québec, Quebec, Canada.
⁴Douglas Mental Health University Institute, Montreal, Canada.
⁵Centre Hospitalier Universitaire de Montréal, Montreal, Canada.
⁶Faculté de Pharmacie d’Angers, Université Angers, Angers, France.
⁷Department of Psychiatry, University of Alberta, Edmonton, Canada.

Background: Measuring cognition in clinical practice is clearly essential to the appropriate characterisation of patients’ clinical status and to the development of a personalised care plan. The Screen for Cognitive Impairment in Psychiatry (SCIP) has been developed in order to provide a brief and accessible tool allowing the evaluation of cognitive function in psychiatric conditions. Objective: We present a validation of a French version of the SCIP. Method: Translation from English into French is carried out using the accepted back-translation method. Seventy-two healthy volunteers are characterised by demographic questionnaires and a neuropsychological battery. The French version of the SCIP is then administered on two separate occasions separated by at least a one-week interval. Results: High internal consistencies as well as strong correlations with comparable neuropsychological tests are obtained. A normalised Cronbach’s α = 0.66 is obtained. Conclusions: The French version of the SCIP (SCIP-F) yields results comparable to the English version. The SCIP represents an essential tool for the preliminary evaluation of cognition. Its characteristics, brevity and the lack of need for a technological platform, allow for its integration into clinical practice. Further testing of SCIP-F in various psychiatric conditions will yield valuable information on its potential in clinical settings.

Screen for Cognitive Impairment in Psychiatry, Cognitive Deficits, Neuropsychological Assessment, Cognitive Screening, Patient-Centered Approaches

Tourjman, S. , Beauchamp, M. , Djouini, A. , Neugot-Cerioli, M. , Gagner, C. , Baruch, P. , Beaulieu, S. , Chanut, F. , Daigneault, A. , Juster, R. , Montmayeur, S. , Potvin, S. , Purdon, S. , Renaud, S. and Villenneuve, E. (2016) French Validation of the Screen for Cognitive Impairment in Psychiatry (SCIP-F). Open Journal of Psychiatry, 6, 107-118. doi: 10.4236/ojpsych.2016.61013.